Report Detail
Global and United States mRNA Vaccines for Infectious Diseases Market Report & Forecast 2022-2028
- RnM4419799 |
- 05 April, 2022 |
- Global |
- 96 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global and United States mRNA Vaccines for Infectious Diseases Market
This report focuses on global and United States mRNA Vaccines for Infectious Diseases market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global mRNA Vaccines for Infectious Diseases market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Infectious Disease Vaccines accounting for % of the mRNA Vaccines for Infectious Diseases global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Infectious Disease was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the mRNA Vaccines for Infectious Diseases market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global mRNA Vaccines for Infectious Diseases Scope and Market Size
mRNA Vaccines for Infectious Diseases market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines for Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the mRNA Vaccines for Infectious Diseases market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the mRNA Vaccines for Infectious Diseases market is segmented into
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application, the mRNA Vaccines for Infectious Diseases market is segmented into
Infectious Disease
Cancer
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and mRNA Vaccines for Infectious Diseases Market Share Analysis
mRNA Vaccines for Infectious Diseases market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in mRNA Vaccines for Infectious Diseases business, the date to enter into the mRNA Vaccines for Infectious Diseases market, Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Table of Contents
1 Study Coverage
- 1.1 mRNA Vaccines for Infectious Diseases Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global mRNA Vaccines for Infectious Diseases Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global mRNA Vaccines for Infectious Diseases Market Size for the Year 2017-2028
- 1.2.2 Global mRNA Vaccines for Infectious Diseases Market Size for the Year 2017-2028
- 1.3 mRNA Vaccines for Infectious Diseases Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States mRNA Vaccines for Infectious Diseases in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of mRNA Vaccines for Infectious Diseases Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 mRNA Vaccines for Infectious Diseases Market Dynamics
- 1.4.1 mRNA Vaccines for Infectious Diseases Industry Trends
- 1.4.2 mRNA Vaccines for Infectious Diseases Market Drivers
- 1.4.3 mRNA Vaccines for Infectious Diseases Market Challenges
- 1.4.4 mRNA Vaccines for Infectious Diseases Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 mRNA Vaccines for Infectious Diseases by Type
- 2.1 mRNA Vaccines for Infectious Diseases Market Segment by Type
- 2.1.1 Infectious Disease Vaccines
- 2.1.2 Cancer Vaccines
- 2.2 Global mRNA Vaccines for Infectious Diseases Market Size by Type (2017, 2022 & 2028)
- 2.3 Global mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2028)
- 2.4 United States mRNA Vaccines for Infectious Diseases Market Size by Type (2017, 2022 & 2028)
- 2.5 United States mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2028)
3 mRNA Vaccines for Infectious Diseases by Application
- 3.1 mRNA Vaccines for Infectious Diseases Market Segment by Application
- 3.1.1 Infectious Disease
- 3.1.2 Cancer
- 3.2 Global mRNA Vaccines for Infectious Diseases Market Size by Application (2017, 2022 & 2028)
- 3.3 Global mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2028)
- 3.4 United States mRNA Vaccines for Infectious Diseases Market Size by Application (2017, 2022 & 2028)
- 3.5 United States mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2028)
4 Global mRNA Vaccines for Infectious Diseases Competitor Landscape by Company
- 4.1 Global mRNA Vaccines for Infectious Diseases Market Size by Company
- 4.1.1 Top Global mRNA Vaccines for Infectious Diseases Companies Ranked by Revenue (2021)
- 4.1.2 Global mRNA Vaccines for Infectious Diseases Revenue by Player (2017-2022)
- 4.2 Global mRNA Vaccines for Infectious Diseases Concentration Ratio (CR)
- 4.2.1 mRNA Vaccines for Infectious Diseases Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of mRNA Vaccines for Infectious Diseases in 2021
- 4.2.3 Global mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global mRNA Vaccines for Infectious Diseases Headquarters, Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global mRNA Vaccines for Infectious Diseases Headquarters and Area Served
- 4.3.2 Global mRNA Vaccines for Infectious Diseases Companies Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into mRNA Vaccines for Infectious Diseases Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States mRNA Vaccines for Infectious Diseases Market Size by Company
- 4.5.1 Top mRNA Vaccines for Infectious Diseases Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States mRNA Vaccines for Infectious Diseases Revenue by Players (2020, 2021 & 2022)
5 Global mRNA Vaccines for Infectious Diseases Market Size by Region
- 5.1 Global mRNA Vaccines for Infectious Diseases Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2028)
- 5.2.1 Global mRNA Vaccines for Infectious Diseases Market Size by Region: 2017-2022
- 5.2.2 Global mRNA Vaccines for Infectious Diseases Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America mRNA Vaccines for Infectious Diseases Market Size YoY Growth 2017-2028
- 6.1.2 North America mRNA Vaccines for Infectious Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe mRNA Vaccines for Infectious Diseases Market Size YoY Growth 2017-2028
- 6.3.2 Europe mRNA Vaccines for Infectious Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America mRNA Vaccines for Infectious Diseases Market Size YoY Growth 2017-2028
- 6.4.2 Latin America mRNA Vaccines for Infectious Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa mRNA Vaccines for Infectious Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Moderna Therapeutics
- 7.1.1 Moderna Therapeutics Company Details
- 7.1.2 Moderna Therapeutics Business Overview
- 7.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Introduction
- 7.1.4 Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.1.5 Moderna Therapeutics Recent Development
- 7.2 CureVac
- 7.2.1 CureVac Company Details
- 7.2.2 CureVac Business Overview
- 7.2.3 CureVac mRNA Vaccines for Infectious Diseases Introduction
- 7.2.4 CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.2.5 CureVac Recent Development
- 7.3 Translate Bio
- 7.3.1 Translate Bio Company Details
- 7.3.2 Translate Bio Business Overview
- 7.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Introduction
- 7.3.4 Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.3.5 Translate Bio Recent Development
- 7.4 BioNTech
- 7.4.1 BioNTech Company Details
- 7.4.2 BioNTech Business Overview
- 7.4.3 BioNTech mRNA Vaccines for Infectious Diseases Introduction
- 7.4.4 BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.4.5 BioNTech Recent Development
- 7.5 Sangamo Therapeutics
- 7.5.1 Sangamo Therapeutics Company Details
- 7.5.2 Sangamo Therapeutics Business Overview
- 7.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Introduction
- 7.5.4 Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.5.5 Sangamo Therapeutics Recent Development
- 7.6 Argos Therapeutics
- 7.6.1 Argos Therapeutics Company Details
- 7.6.2 Argos Therapeutics Business Overview
- 7.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Introduction
- 7.6.4 Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.6.5 Argos Therapeutics Recent Development
- 7.7 In-Cell-Art
- 7.7.1 In-Cell-Art Company Details
- 7.7.2 In-Cell-Art Business Overview
- 7.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Introduction
- 7.7.4 In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.7.5 In-Cell-Art Recent Development
- 7.8 eTheRNA
- 7.8.1 eTheRNA Company Details
- 7.8.2 eTheRNA Business Overview
- 7.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Introduction
- 7.8.4 eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.8.5 eTheRNA Recent Development
- 7.9 Ethris
- 7.9.1 Ethris Company Details
- 7.9.2 Ethris Business Overview
- 7.9.3 Ethris mRNA Vaccines for Infectious Diseases Introduction
- 7.9.4 Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.9.5 Ethris Recent Development
- 7.10 Tiba Biotechnology
- 7.10.1 Tiba Biotechnology Company Details
- 7.10.2 Tiba Biotechnology Business Overview
- 7.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Introduction
- 7.10.4 Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
- 7.10.5 Tiba Biotechnology Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Get latest Market Research Reports on mRNA Vaccines for Infectious Diseases. Industry analysis & Market Report on mRNA Vaccines for Infectious Diseases is a syndicated market report, published as Global and United States mRNA Vaccines for Infectious Diseases Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of mRNA Vaccines for Infectious Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
